Replies to post #133469 on Biotech Values

[hptaxis]

WTF is synthetic DNA-based technology?

As previously announced on November 22, 2011 , the Company and Intrexon Corporation ("Intrexon") entered into a worldwide exclusive channel collaboration for the development and commercialization of a synthetic DNA-based therapy to treat pulmonary arterial hypertension (PAH).

http://finance.yahoo.com/news/Adeona-Announces-Proposed-prnews-1391049483.html?x=0

[DewDiligence]

AEN* changes CEO yet another time:

http://finance.yahoo.com/news/Adeona-Announces-Executive-prnews-4247231273.html?x=0

Jeff Riley, a member of the Adeona Board of Directors since March 2010 and Chairman of the Board since November 2011, was appointed as the Company's President and Chief Eexcutive Officer. James S. Kuo will continue to serve on the Company's Board of Directors, having resigned from his day-to-day management positions to pursue other opportunities.

Let’s recap: In a period of about four years, Jeff Riley replaced James Kuo who replaced Max Lyon who replaced Steve Kanzer (the second time) who replaced Nicholas Stergis who replaced Steve Kanzer!! What a freaking joke this company is.

*Soon to be renamed Synthetic Biologics (#msg-70156631), LOL